Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers

Trial Profile

Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs SQ 109 (Primary)
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Sponsors Sequella
  • Most Recent Events

    • 16 Nov 2015 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
    • 14 May 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
    • 14 May 2013 Planned End Date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top